Davide Nicoli

Davide Nicoli

Auto-generated profile, based on publicly available information

Davide Nicoli

Molecular Biology Laboratory, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2010 in Brain and Development
Verified
Journal Article
Closed access
CFCarlo Fusco
Carlo Fusco
DFDaniele Frattini
Daniele Frattini
EFEnrico Farnetti
Enrico Farnetti
DNDavide Nicoli
Davide Nicoli
BCBruno Casali
Bruno Casali
EGElvio Della Giustina
Elvio Della Giustina

1 September 2004
Verified
Journal Article
Closed access
SCSalvarani Carlo
Salvarani Carlo
LBLuigi Boiardi
Luigi Boiardi
BCBruno Casali
Bruno Casali
IOIgnazio Olivieri
Ignazio Olivieri
FCFabrizio Cantini
Fabrizio Cantini
LPLia Pulsatelli
Lia Pulsatelli

1 October 2003
Verified
Journal Article
Closed access
LBLuigi Boiardi
Luigi Boiardi
BCBruno Casali
Bruno Casali
DNDavide Nicoli
Davide Nicoli
EFEnrico Farnetti
Enrico Farnetti
QCQingquan Chen
Qingquan Chen
SCSalvarani Carlo
Salvarani Carlo

7 April 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
VMVincenzo Dario Mandato
Vincenzo Dario Mandato
EFEnrico Farnetti
Enrico Farnetti
FTFederica Torricelli
Federica Torricelli
MAMartino Abrate
Martino Abrate
BCBruno Casali
Bruno Casali
Stefano PalombaStefano Palomba
Stefano Palomba
HNF1B (formerly known as TCF2) gene encodes for a transcription factor that regulates gene expression involved in normal mesodermal and endodermal developments. A close association between rs4430796 polymorphism of HNF1B gene and decreased endometrial cancer (EC) risk has been demonstrated. The aim of the current study was to test the hypothesis that rs4430796 polymorphism can influence the prognosis of EC patients. Retrospective cohort study. Clinical and pathological data were extrapolated and genotypes were assessed on formalin-fixed and paraffin-embedded non-tumour tissues. The influence of patients’ genotype on overall survival and progression free survival were our main outcome measures. A total of 191 EC patients were included in the final analysis. Overall survival differed significantly (P = 0.003) among genotypes. At multivariate analysis, a significant (P < 0.05) effect on overall survival was detected for FIGO stage, and rs4430796 polymorphism of HNF1B gene. After grouping EC patients according to adjuvant treatment, rs4430796 polymorphism resulted significantly (P < 0.001) related to overall survival only in subjects who received radiotherapy plus chemotherapy. A significant (P = 0.014) interaction between rs4430796 polymorphism and chemo-radiotherapy was also detected. Finally, only a trend (P = 0.090) towards significance was observed for rs4430796 polymorphism effect on progression free survival. rs4430796 polymorphism of HNF1B gene influences independently the prognosis of EC patients with a potential effect on tumor chemo-sensitivity.

1 March 2002
Verified
Journal Article
Closed access
SCSalvarani Carlo
Salvarani Carlo
LBLuigi Boiardi
Luigi Boiardi
BCBruno Casali
Bruno Casali
IOIgnazio Olivieri
Ignazio Olivieri
GCGiovanni Ciancio
Giovanni Ciancio
PMPierluigi Macchioni
Pierluigi Macchioni

1 October 2012
Verified
Journal Article
Closed access
VMVincenzo Dario Mandato
Vincenzo Dario Mandato
EMElena Magnani
Elena Magnani
MAMartino Abrate
Martino Abrate
BCBruno Casali
Bruno Casali
DNDavide Nicoli
Davide Nicoli
GSGiovanni Battista La Sala
Giovanni Battista La Sala